bluebird bio, Inc. secures up to $175 million debt financing with Hercules Capital for commercial launches of FDA approved gene therapies.
Amount Raised
$175 Million
Round Type
Debt Financing
SomervilleBiotechnologyHealth CareTherapeuticsInvestors
Description
bluebird bio, Inc. has entered into a $175 million five-year term loan facility with Hercules Capital, Inc. to strengthen its balance sheet for the commercial launches of its three FDA approved gene therapies - LYFGENIA for sickle cell disease, ZYNTEGLO for beta-thalassemia, and SKYSONA for cerebral adrenoleukodystrophy.
Quick answer
bluebird bio raised $175 Million in a Debt Financing round, dated March 18, 2024. Investors: Hercules Capital. bluebird bio is based in Somerville, Massachusetts, United States.
- How much did bluebird bio raise?
- bluebird bio raised $175 Million in a Debt Financing round on March 18, 2024.
- Who invested in bluebird bio?
- Hercules Capital is named as investors in this round.
- What does bluebird bio do?
- bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases.
- Where is bluebird bio based and how big is it?
- bluebird bio is based in Somerville, Massachusetts, United States. Fundz records about 449 employees.
- Who are the decision-makers at bluebird bio?
- Fundz holds 1 contact at bluebird bio, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as bluebird bio that raised within 45 days of this round, from Fundz verified event records.
- Scipher Medicine raised $25M on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
- Cerevance raised $47M (Series B) on April 29, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
Who to call at bluebird bio, and when
A new round usually means bluebird bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day bluebird bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at bluebird bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at bluebird bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment bluebird bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
bluebird bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.